Your browser doesn't support javascript.
loading
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma.
Lobello, Cosimo; Tichy, Boris; Bystry, Vojtech; Radova, Lenka; Filip, Daniel; Mraz, Marek; Montes-Mojarro, Ivonne-Aidee; Prokoph, Nina; Larose, Hugo; Liang, Huan-Chang; Sharma, Geeta G; Mologni, Luca; Belada, David; Kamaradova, Katerina; Fend, Falko; Gambacorti-Passerini, Carlo; Merkel, Olaf; Turner, Suzanne D; Janikova, Andrea; Pospisilova, Sarka.
Affiliation
  • Lobello C; Center of Molecular Medicine, Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
  • Tichy B; Center of Molecular Medicine, Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
  • Bystry V; Center of Molecular Medicine, Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
  • Radova L; Center of Molecular Medicine, Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
  • Filip D; Center of Molecular Medicine, Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
  • Mraz M; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Medical Faculty MU, Brno, Czech Republic.
  • Montes-Mojarro IA; Center of Molecular Medicine, Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
  • Prokoph N; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Medical Faculty MU, Brno, Czech Republic.
  • Larose H; Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard Karls University, Tübingen, Germany.
  • Liang HC; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK.
  • Sharma GG; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK.
  • Mologni L; Department of Pathology, Medical University of Vienna, Vienna, Austria.
  • Belada D; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Kamaradova K; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Fend F; 4th Department of Internal Medicine-Hematology, Charles University Hospital and Faculty of Medicine, Hradec Králové, Czech Republic.
  • Gambacorti-Passerini C; Fingerland Department of Pathology, Charles University Hospital and Faculty of Medicine, Hradec Králové, Czech Republic.
  • Merkel O; Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard Karls University, Tübingen, Germany.
  • Turner SD; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Janikova A; Department of Pathology, Medical University of Vienna, Vienna, Austria.
  • Pospisilova S; Center of Molecular Medicine, Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
Leukemia ; 35(5): 1500-1505, 2021 05.
Article in En | MEDLINE | ID: mdl-33247178
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / Lymphoma, Large-Cell, Anaplastic / STAT3 Transcription Factor / Mutation Type of study: Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / Lymphoma, Large-Cell, Anaplastic / STAT3 Transcription Factor / Mutation Type of study: Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Year: 2021 Type: Article